newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Focus remains on cost control to maximize the value of our royalty assets Company announces evaluation of strategic alternatives TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ:TXMD), a company